Navigation Links
Addrenex Pharmaceuticals Announces Positive Phase III Clinical Results for Clonicel to Treat ADHD
Date:9/10/2008

and approval by the FDA, hopefully by next year."

The study showed that Clonicel was statistically superior to placebo on the primary endpoint, the ADHD Rating Scale of 18 symptoms. Clonicel was also statistically superior to placebo on several secondary scales completed by clinicians and parents, including a scale that assesses adrenergic dysregulation. The scale was designed by Joseph Horacek, M.D., a Charlotte neuropsychiatrist and cofounder of Addrenex. Side effects were generally mild to moderate in severity, and no serious adverse events were reported in the study.

A total of 228 children between the ages of 6 and 17 with a diagnosis of ADHD participated in the randomized, double-blind, placebo-controlled trial that compared two doses of Clonicel, 0.2 mg per day and 0.4 mg per day, with placebo. Children received either study medication or placebo for eight weeks at one of 13 study centers nationwide.

If Clonicel is approved by the Food and Drug Administration, the new drug will be marketed by Sciele Pharma under an agreement signed with Addrenex in July 2007.

The introduction of Clonicel into the ADHD market would fill a void that currently exists in the treatment of ADHD, Khayrallah said. While stimulants play an important role in treating ADHD, they do not address all of the symptoms associated with the disorder and may result in unacceptable side effects in some patients.

Because Clonicel targets receptors within the body's stress response center -- the adrenergic system -- it may be more effective in alleviating lesser-known symptoms that accompany ADHD, such as emotional outbursts, mood swings, irritability and hyperreactivity to stress, Horacek said.

"We believe that Clonicel is normalizing the excess of the adrenergic hormones that contribute to many of the symptoms of ADHD," said Horacek.

Stress hormones produce a rapid heart rate, elevated blood pressure, sweating, temperature increases, heightened an
'/>"/>

SOURCE Addrenex
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Addrenex Pharmaceuticals New Hires Further Company Goal to Identify New Drugs for Adrenergic Regulation
2. Celator Pharmaceuticals Receives Orphan Drug Designation for Anticancer Agent CPX-351
3. Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients
4. Aegerion Pharmaceuticals, Inc. adds Peter Garrambone to Board of Directors, Secures Additional Capital for Clinical Trials
5. Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD)
6. Panacea Pharmaceuticals Announces Issuance of a U.S. Patent Covering Anti-HAAH Antibodies
7. Anthera Pharmaceuticals Advances Global Development Strategy for Varespladib in Patients With Acute Coronary Syndrome With the Initiation of FRANCIS Trial
8. Indevus Pharmaceuticals Announces Completion of Enrollment in Phase III Trial of PRO 2000
9. Vion Pharmaceuticals Enters Into Agreement With HOVON to Conduct a Phase III Clinical Trial of Cloretazine(R) in Combination With Frontline AML and MDS Therapy
10. Oramed Pharmaceuticals Chosen to Present Oral Insulin Trial Results at EASD Conference (September 7-11, Rome)
11. Peregrine Pharmaceuticals Doses First Patient in Phase II Trial of Bavituximab in Patients With Advanced Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... , Sept. 17, 2014 Germany Gynecological ... GlobalData,s new report, "Germany Gynecological Devices Market ... the Germany Gynecological Devices market. The report provides ... units) and average prices (in US dollars) within ... Devices (Micro-inserts) and Mechanical Sterilization Devices (Tubal Clips ...
(Date:9/17/2014)... NEW YORK , Sept. 17, 2014 ... of PDL BioPharma, Inc. ("PDL BioPharma" or the "Company") ... Robert S. Willoughby at rswilloughby@pomlaw.com or ... PDL BioPharma and certain of its officers and/or directors ... Exchange Act of 1934.  On September ...
(Date:9/17/2014)... 17, 2014 Bronstein, Gewirtz & Grossman, LLC ... the securities of PDL BioPharma, Inc. ("PDL BioPharma" or ... investors are advised to contact Peretz Bronstein ... at info@bgandg.com or 212-697-6484. The ... its executives violated federal securities laws. On ...
Breaking Medicine Technology:Germany Gynecological Devices Market Outlook to 2020 2Germany Gynecological Devices Market Outlook to 2020 3SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PDL BioPharma, Inc. - PDLI 2Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Investigates claims on behalf of Investors of PDL BioPharma, Inc. --PDLI 2
(Date:9/18/2014)... September 18, 2014 For many people, tomato ... an online food delivery service provider, gives it a new ... Tomato Basil soup is a nod to this culinary classic—with ... a tangy tomato base, then Spoonful of Comfort's chefs stir ... A flashback to childhood has never tasted better. , ...
(Date:9/18/2014)... Computer Resources of America, Inc. (CRA), ... York City, has been awarded a contract to provide ... with stores in over 150 countries. The services will ... being the retailer’s dispatch arm handling all IT support ... Chief Executive Officer of CRA said, “We are excited ...
(Date:9/18/2014)... Albany, NY (PRWEB) September 18, 2014 ... foods, which have special functions of adjusting human ... etc., have won great popularity with a variety ... of health food in China reached RMB187.4 billion, ... of 22.1% during 2006-2013. , View Full Report ...
(Date:9/18/2014)... Boston, MA (PRWEB) September 18, 2014 ... train its team and surgeon partners in Less ... to joining SpineFrontier, Tamara authored an extensive education ... holds a Masters in Science in Organizational Leadership, ... multiple industries for eleven years. Bringing her to ...
(Date:9/18/2014)... September 18, 2014 Dr. Suzaunna Clark, ... 1- sometimes, inner beauty has to be seen to ... be acknowledged in order to be used. Together, both ... shows the world how to do both. ... Coaching using the Healing Hearts system, which provides professional ...
Breaking Medicine News(10 mins):Health News:An Old Classic Brings New Soup Delivery Options to Spoonful of Comfort 2Health News:CRA Awarded Managed Support Contract for Global Retailer 2Health News:China Health Food Industry Size 2014 Market Analysis, Growth, Trends and Forecast Report 2017: MarketResearchReports.biz 2Health News:China Health Food Industry Size 2014 Market Analysis, Growth, Trends and Forecast Report 2017: MarketResearchReports.biz 3Health News:China Health Food Industry Size 2014 Market Analysis, Growth, Trends and Forecast Report 2017: MarketResearchReports.biz 4Health News:SpineFrontier Inc. Makes Bold Move to Expand Its Internal Training Team to Collaborate With The LESSociety’s Less Exposure Surgery® University To Educate Surgeons. 2Health News:Suzaunna-Where Life! Happens Announces the Launch of Healing Hearts 2Health News:Suzaunna-Where Life! Happens Announces the Launch of Healing Hearts 3
... seek answers to questions of motivation and self-actualization. "Make ... Honaman employs lessons learned in his career working with ... to help others direct their energies and develop their ... "Make It Happen" that personal branding is the process ...
... 20 Hooper Holmes, Inc. (Amex: HH ... Health and Wellness Division, Christopher J. Behling, will be ... Colloquium on Tuesday, March 3, 2009 at 9:00 a.m. ... Regency at Penn,s Landing in Philadelphia, Pennsylvania. Mr. Behling,s ...
... Faced with news of increasing layoffs, straining economic times, ... hiring is based on looks, millions of American women ... them a competitive edge in the workplace. In a ... of 18 and 64 compiled by the ASPS, many ...
... 20 The Niwano Peace Foundation announced Friday it will ... Baguma Byamugisha, an Anglican priest of Uganda, in recognition of ... people living with HIV/AIDS.An award presentation ceremony will take place ... award certificate, Rev. Byamugisha will receive a medal and 20 ...
... York, NY, February 20, 2009 Although widespread Prostate-Specific-Antigen ... there a point of diminishing returns? In a study ... Journal of Urology , researchers found that in a ... years old or older and had a PSA below ...
... in chronic obstructive lung disease (COPD) themselves increase ... days of full, asymptomatic recoverybad news for patients ... progression of the disease. , "This concept ... for the analysis of clinical trial data and ...
Cached Medicine News:Health News:Business Strategist Applies Corporate Experience to Self-Help: 'Make It Happen' 2Health News:Hooper Holmes to Present at the Ninth Population Health and Disease Management Colloquium 2Health News:Hooper Holmes to Present at the Ninth Population Health and Disease Management Colloquium 3Health News:In Today's Economy, Women In The Workforce Link Cosmetic Chicago Plastic Surgery To Success 2Health News:In Today's Economy, Women In The Workforce Link Cosmetic Chicago Plastic Surgery To Success 3Health News:Rev. Byamugisha of Uganda to Receive Niwano Peace Prize 2Health News:When should prostate-specific antigen testing be stopped? 2Health News:Exacerbations in COPD: One thing leads to another 2Health News:Exacerbations in COPD: One thing leads to another 3